<?xml version="1.0" encoding="UTF-8" standalone="no"?><information><Cell><NavigationPath><Head00/><Stub><StubValue>2. Oral absorption</StubValue></Stub><HeaderValue/></NavigationPath><value>• Patient tolerates oral fluids• No medical problems leading to reduced oral absorption (e. g. vomiting, diarrhoea, and gastrointestinal surgery)• No surgical operation scheduled within next 36 hours</value><CellType>Text</CellType></Cell><Table><TableType>Key-Value</TableType><tableName>IV to oral switch inclusion criteria used</tableName><tableOrder>Table 1</tableOrder><tableFooter/></Table><Document><DocumentTitle>A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay</DocumentTitle><PMC>1513579</PMC></Document></information>
